HPV‐Associated Tumor Eradication by Vaccination with Synthetic Short Peptides and Particle‐Forming Liposomes

Antibody response of a particle-inducing, liposome vaccine adjuvant admixed with a Pfs230 fragment

(2020) Wei-Chiao Huang et al.   npj Vaccines

Prevention and treatment of cervical cancer by a single administration of human papillomavirus peptide vaccine with CpG oligodeoxynucleotides as an adjuvant in vivo

(2019) Yang Yang et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Synergistic STING activation by PC7A nanovaccine and ionizing radiation improves cancer immunotherapy

(2019) Min Luo et al.   JOURNAL OF CONTROLLED RELEASE

Vaccination with synthetic long peptide formulated with CpG in an oil-in-water emulsion induces robust E7-specific CD8 T cell responses and TC-1 tumor eradication

(2019) Sean K. Maynard et al.   BMC CANCER

Immunogenicity of the Lyme disease antigen OspA, particleized by cobalt porphyrin-phospholipid liposomes

(2019) Jasmin Federizon et al.   VACCINE

An Engineered Biomimetic MPER Peptide Vaccine Induces Weakly HIV Neutralizing Antibodies in Mice

(2019) Shuai Shao et al.   ANNALS OF BIOMEDICAL ENGINEERING

Correlates of adjuvanticity: A review on adjuvants in licensed vaccines

(2018) Giuseppe Del Giudice et al.   SEMINARS IN IMMUNOLOGY

Nanoparticle conjugation of human papillomavirus 16 E7-long peptides enhances therapeutic vaccine efficacy against solid tumors in mice

(2018) Gabriele Galliverti et al.   Cancer Immunology Research

A malaria vaccine adjuvant based on recombinant antigen binding to liposomes

(2018) Wei-Chiao Huang et al.   Nature Nanotechnology

A STING-activating nanovaccine for cancer immunotherapy

(2017) Min Luo et al.   Nature Nanotechnology

Control of immune escaped human papilloma virus is regained after therapeutic vaccination

(2017) Wenbo Ma et al.   Current Opinion in Virology

Efficient Eradication of Established Tumors in Mice with Cationic Liposome-Based Synthetic Long-Peptide Vaccines

(2017) Eleni Maria Varypataki et al.   Cancer Immunology Research

Adjuvant system AS01: helping to overcome the challenges of modern vaccines

(2016) Arnaud M. Didierlaurent et al.   Expert Review of Vaccines

HPV16 variants distribution in invasive cancers of the cervix, vulva, vagina, penis, and anus

(2016) Sara Nicolás-Párraga et al.   Cancer Medicine

Adjuvants for peptide-based cancer vaccines

(2016) Hiep Khong et al.   Journal for ImmunoTherapy of Cancer

Gapped sequence alignment using artificial neural networks: application to the MHC class I system

(2015) Massimo Andreatta et al.   BIOINFORMATICS

Polymeric nanoparticles for co-delivery of synthetic long peptide antigen and poly IC as therapeutic cancer vaccine formulation

(2015) Sima Rahimian et al.   JOURNAL OF CONTROLLED RELEASE

Functionalization of cobalt porphyrin–phospholipid bilayers with his-tagged ligands and antigens

(2015) Shuai Shao et al.   Nature Chemistry

Co-administration with DNA encoding papillomavirus capsid proteins enhances the antitumor effects generated by therapeutic HPV DNA vaccination

(2015) Benjamin Yang et al.   Cell and Bioscience

Oral vaccination against HPV E7 for treatment of cervical intraepithelial neoplasia grade 3 (CIN3) elicits E7-specific mucosal immunity in the cervix of CIN3 patients

(2014) Kei Kawana et al.   VACCINE

Clearance of persistent HPV infection and cervical lesion by therapeutic DNA vaccine in CIN3 patients

(2014) Tae Jin Kim et al.   Nature Communications

Understanding the Biology of Antigen Cross-Presentation for the Design of Vaccines Against Cancer

(2014) Cynthia M. Fehres et al.   Frontiers in Immunology

BiVax: a peptide/poly-IC subunit vaccine that mimics an acute infection elicits vast and effective anti-tumor CD8 T-cell responses

(2012) Hyun-Il Cho et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

TriVax-HPV: an improved peptide-based therapeutic vaccination strategy against human papillomavirus-induced cancers

(2012) Kelly Barrios et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Preventing Cancer with Vaccines: Progress in the Global Control of Cancer

(2012) M. A. Kane   Cancer Prevention Research

Targeting tumor antigens to dendritic cells using particulate carriers

(2012) Medha D. Joshi et al.   JOURNAL OF CONTROLLED RELEASE

Presentation of Phagocytosed Antigens by MHC Class I and II

(2012) Adriana R. Mantegazza et al.   TRAFFIC

Route of Administration Modulates the Induction of Dendritic Cell Vaccine-Induced Antigen-Specific T Cells in Advanced Melanoma Patients

(2011) W. J. Lesterhuis et al.   CLINICAL CANCER RESEARCH

Recombinant HPV16 E7 assembled into particles induces an immune response and specific tumour protection administered without adjuvant in an animal model

(2011) Linda Petrone et al.   Journal of Translational Medicine

A novel self-assembled nanoparticle vaccine with HIV-1 Tat49-57/HPV16 E749-57 fusion peptide and GM-CSF DNA elicits potent and prolonged CD8+ T cell-dependent anti-tumor immunity in mice

(2011) Jun Tang et al.   VACCINE

Success or failure of vaccination for HPV16-positive vulvar lesions correlates with kinetics and phenotype of induced T-cell responses

(2010) M. J. P. Welters et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Carrageenan as an adjuvant to enhance peptide-based vaccine potency

(2010) Yu-Qian Zhang et al.   VACCINE

A novel fusion protein-based vaccine comprising a cell penetrating and immunostimulatory peptide linked to human papillomavirus (HPV) type 16 E7 antigen generates potent immunologic and anti-tumor responses in mice

(2010) Milaid Granadillo et al.   VACCINE

Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia

(2009) Gemma G. Kenter et al.   NEW ENGLAND JOURNAL OF MEDICINE

The first clinical use of a live-attenuated Listeria monocytogenes vaccine: A Phase I safety study of Lm-LLO-E7 in patients with advanced carcinoma of the cervix

(2009) Paulo Cesar Maciag et al.   VACCINE

Phase I Immunotherapeutic Trial with Long Peptides Spanning the E6 and E7 Sequences of High-Risk Human Papillomavirus 16 in End-Stage Cervical Cancer Patients Shows Low Toxicity and Robust Immunogenicity

(2008) G. G. Kenter et al.   CLINICAL CANCER RESEARCH

Induction of Cytotoxic T-Lymphocytes and Antitumor Activity by a Liposomal Lipopeptide Vaccine

(2008) Weihsu Chen et al.   MOLECULAR PHARMACEUTICS